ArticleBritish journal of cancer2018

Comment on "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer".

Burak Uzunparmak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.